Abstract:Background and aim: The study aims to develop a hybrid machine learning model for predicting resectability of the pancreatic cancer, which is based on computed tomography (CT) and National Comprehensive Cancer Network (NCCN) guidelines. Method: We retrospectively studied 349 patients. One hundred seventy-one cases from Center 1 and 92 cases from Center 2 were used as the primary training cohort, and 66 cases from Center 3 and 20 cases from Center 4 were used as the independent test dataset. Semi-automatic module of ITK-SNAP software was used to assist CT image segmentation to obtain three-dimensional (3D) imaging region of interest (ROI). There were 788 handcrafted features extracted for 3D ROI using PyRadiomics. The optimal feature subset consists of three features screened by three feature selection methods as the input of the SVM to construct the conventional radiomics-based predictive model (cRad). 3D ROI was used to unify the resolution by 3D spline interpolation method for constructing the 3D tumor imaging tensor. Using 3D tumor image tensor as input, 3D kernelled support tensor machine-based predictive model (KSTM), and 3D ResNet-based deep learning predictive model (ResNet) were constructed. Multi-classifier fusion ML model is constructed by fusing cRad, KSTM, and ResNet using multi-classifier fusion strategy. Two experts with more than 10 years of clinical experience were invited to reevaluate each patient based on their CECT following the NCCN guidelines to obtain resectable, unresectable, and borderline resectable diagnoses. The three results were converted into probability values of 0.25, 0.75, and 0.50, respectively, according to the traditional empirical method. Then it is used as an independent classifier and integrated with multi-classifier fusion machine learning (ML) model to obtain the human-machine fusion ML model (HMfML). Results: Multi-classifier fusion ML model's area under receiver operating characteristic curve (AUC; 0.8610), predictive accuracy (ACC: 80.23%), sensitivity (SEN: 78.95%), and specificity (SPE: 80.60%) is better than cRad, KSTM, and ResNet-based single-classifier models and their two-classifier fusion models. This means that three different models have mined complementary CECT feature expression from different perspectives and can be integrated through CFS-ER, so that the fusion model has better performance. HMfML's AUC (0.8845), ACC (82.56%), SEN (84.21%), SPE (82.09%). This means that ML models might learn extra information from CECT that experts cannot distinguish, thus complementing expert experience and improving the performance of hybrid ML models. Conclusion: HMfML can predict PC resectability with high accuracy.

Siamese Delta Network with Multimodality Fusion for Systemic Treatment Response Prediction in Pancreatic Cancer*

A machine learning based delta-radiomics process for early prediction of treatment response of pancreatic cancer

Computed Tomography-Based Delta Radiomics of Tumor Core-Edge Combination for Systemic Treatment Response Evaluation in Pancreatic Cancer

Radiomic Biomarkers from PET/CT Multi-Modality Fusion Images for the Prediction of Immunotherapy Response in Advanced Non-Small Cell Lung Cancer Patients.

A Multimodal Model Fusing Multiphase Contrast-Enhanced CT and Clinical Characteristics for Predicting Lymph Node Metastases of Pancreatic Cancer

Mesothelin expression prediction in pancreatic cancer based on multimodal stochastic configuration networks

Ssm-Net: Semi-Supervised Multi-Task Network for Joint Lesion Segmentation and Classification from Pancreatic Eus Images

Automated diagnosis of pancreatic mucinous and serous cystic neoplasms with modality-fusion deep neural network using multi-modality MRIs

Prediction of New-Onset Diabetes after Pancreatectomy with Subspace Clustering Based Multi-View Feature Selection

Multiscale and multiperception feature learning for pancreatic lesion detection based on noncontrast CT

Joint Radiomics Analysis on 18F-FDG-PET-MRI of Primary Tumor to Predict the Risk of Synchronous Distant Metastasis in Pancreatic Ductal Adenocarcinoma

Improving prognostic performance in resectable pancreatic ductal adenocarcinoma using radiomics and deep learning features fusion in CT images

SAMA: A Self-and-Mutual Attention Network for Accurate Recurrence Prediction of Non-Small Cell Lung Cancer Using Genetic and CT Data

Prediction of Tumor-Infiltrating CD20+ B-Cells in Patients with Pancreatic Ductal Adenocarcinoma Using a Multilayer Perceptron Network Classifier Based on Non-contrast MRI

Computed tomography and guidelines-based human-machine fusion model for predicting resectability of the pancreatic cancer

A machine learning model based on clinical features and ultrasound radiomics features for pancreatic tumor classification

Integrating image and gene-data with a semi-supervised attention model for prediction of KRAS gene mutation status in non-small cell lung cancer

Attention-enhanced multiscale feature fusion network for pancreas and tumor segmentation

DSMT-Net: Dual Self-supervised Multi-operator Transformation for Multi-source Endoscopic Ultrasound Diagnosis

A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer

Cancer immunotherapy response prediction from multi-modal clinical and image data using semi-supervised deep learning